Nanobody approval gives domain antibodies a boost

The FDA has approved a first nanobody, lifting hopes for companies that are exploring innovative uses for domain antibodies.

Search for this author in:

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 18, 485-487 (2019)

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.